nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice
|
Pereira, Venúcia B. M. |
|
2015 |
77 |
2 |
p. 323-332 |
artikel |
2 |
A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis
|
Eads, Jennifer R. |
|
2015 |
77 |
2 |
p. 333-338 |
artikel |
3 |
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
|
Kumar, Rajiv |
|
2015 |
77 |
2 |
p. 375-383 |
artikel |
4 |
A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects
|
Mondal, Sabiha A. |
|
2016 |
77 |
2 |
p. 251-258 |
artikel |
5 |
A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin
|
Agarwal, Neeraj |
|
2015 |
77 |
2 |
p. 299-308 |
artikel |
6 |
Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer
|
Rajagopalan, Prasanna |
|
2016 |
77 |
2 |
p. 393-404 |
artikel |
7 |
Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes
|
Lin, Qian |
|
2015 |
77 |
2 |
p. 269-280 |
artikel |
8 |
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy
|
Marachelian, Araz |
|
2016 |
77 |
2 |
p. 405-412 |
artikel |
9 |
Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer
|
Bendell, Johanna C. |
|
2015 |
77 |
2 |
p. 439 |
artikel |
10 |
Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study
|
Nagamatsu, Hiroaki |
|
2016 |
77 |
2 |
p. 243-250 |
artikel |
11 |
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents
|
Casanova, Michela |
|
|
77 |
2 |
p. 289-298 |
artikel |
12 |
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents
|
Casanova, Michela |
|
2015 |
77 |
2 |
p. 289-298 |
artikel |
13 |
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study
|
König, Miriam |
|
2016 |
77 |
2 |
p. 413-427 |
artikel |
14 |
In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine
|
Fandy, Tamer E. |
|
2015 |
77 |
2 |
p. 259-267 |
artikel |
15 |
Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma
|
Koo, Dong-Hoe |
|
2015 |
77 |
2 |
p. 339-347 |
artikel |
16 |
Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
|
Perroud, Herman Andres |
|
2015 |
77 |
2 |
p. 365-374 |
artikel |
17 |
Metformin and pancreatic cancer: Is there a role?
|
Souza, Andre De |
|
2016 |
77 |
2 |
p. 235-242 |
artikel |
18 |
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases
|
Siqing, Fu |
|
2015 |
77 |
2 |
p. 357-364 |
artikel |
19 |
Pharmacokinetic interaction between pazopanib and cisplatin regimen
|
Imbs, Diane-Charlotte |
|
2016 |
77 |
2 |
p. 385-392 |
artikel |
20 |
Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression
|
Martínková, Jiřina |
|
2015 |
77 |
2 |
p. 429-437 |
artikel |
21 |
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines
|
Ye, Shunan |
|
2015 |
77 |
2 |
p. 349-356 |
artikel |
22 |
Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity
|
Galal, Aya |
|
2015 |
77 |
2 |
p. 309-322 |
artikel |
23 |
Treatment regimens of classical and newer taxanes
|
Joerger, Markus |
|
2015 |
77 |
2 |
p. 221-233 |
artikel |
24 |
Validity of new methods to evaluate renal function in cancer patients treated with cisplatin
|
Funakoshi, Yohei |
|
2016 |
77 |
2 |
p. 281-288 |
artikel |